View on Pubmed.gov 33633511 | View on doi.org 10.1177/1559325...
Pro-Inflammatory Cytokines at Ultra-Low Dose Exert Anti-Inflammatory Effect In Vitro: A Possible Mode of Action Involving Sub-Micron Particles?
- Preclinical Research, Clinical Research, Regulatory Affairs Departments, Labo'Life France, Nantes, France.
- VivaCell Biotechnology GmbH, Denzlingen, Germany.
- Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
- Izon Science Europe SAS, Lyon, France.
Abstract
Tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) are pro-inflammatory cytokines involved in acute and chronic inflammatory diseases. Indeed, immunotherapy blocking these 2 cytokines has been developed. Micro-immunotherapy (MI) also uses ultra-low doses (ULD) of pro-inflammatory cytokines, impregnated on lactose-sucrose pillules, to counteract their overexpression. The study has been conducted with 2 objectives: examine the anti-inflammatory effect in vitro and the capacity of 2 unitary medicines, TNF-α (27 CH) and IL-1β (27 CH), to reduce the secretion of TNF-α in human primary monocytes and THP-1 cells differentiated with phorbol-12-myristate-13-acetate, after lipopolysaccharide (LPS) exposure; then, investigate the presence of particles possibly containing starting materials using tunable resistive pulse sensing technique. The results show that the unitary medicines, tested at 3 pillules concentrations (5.5, 11 and 22 mM), have reduced the secretion of TNF-α in both models by about 10-20% vs. vehicle control, depending on concentration. In this exploratory study, particles (150-1000 nm) have been detected in MI ULD-impregnated pillules and a hypothesis for MI medicines mode of action has been proposed. Conscious that more evaluations are necessary, authors are cautious in the conclusions because the findings described in the study are still limited, and future investigations may lead to different hypothesis.
References
Exp Cell Res. 1991 Jan;192(1):52-60
Neurosci Lett. 2004 May 6;361(1-3):184-7
Degener Neurol Neuromuscul Dis. 2019 Jul 08;9:79-88
Homeopathy. 2010 Oct;99(4):231-42
Cited by 19 citations (total)
Journal Article
Special Focus on the Cellular Anti-Inflammatory Effects of Several Micro-Immunotherapy Formulations: Considerations Regarding Intestinal-, Immune-Axis-Related- and Neuronal-Inflammation Contexts.
Electronic publication date December 21, 2022
Camille Jacques [...] Ilaria Floris et al.
Introduction
Chronic inflammation is a pernicious underlying status, well-known for its contribution to the progressive development of various diseases. In this...
Journal Article
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV Active Ingredients.
Electronic publication date January 23, 2024
Camille Jacques [...] Ilaria Floris et al.
BACKGROUND
Epstein-Barr virus (EBV) is often kept silent and asymptomatic; however, its reactivation induces a chronic and/or recurrent infection that is...
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: IF and BL work for Labo’Life France, the company service provider of Labo’Life, specialized in preclinical and clinical research, as well as regulatory affairs. This professional relationship does not imply any misconduct on the part of the authors. KA and TR work for Vivacell, Biotechnology GmbH, a biotechnological company specialized in preclinical research. JACR works in the Instituto Maimónides de Investigación Biomédica of Córdoba. CR works for Izon Science Europe SAS.
MeSH
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
Copyright
© The Author(s) 2020.